Corporate Info Research Reports Consulting News Contact Us
 

 

Free Research Reports

Complete the surveys below to get free findings from each study!

All Current Studies

Brand Development & Launch

Consulting Services

Let Cutting Edge Information help you build revenues, reduce costs, and increase efficiency.

Call Yanis Saradjian at 919-433-0206 today to learn more about our customized research and get a free quote.

 

Business Development: Accelerating the Deal (PH118)

Purchase E-Copy Now
Download Free Report Summary

Published 2008
174 Pages
400+ Metrics
60+ Charts and Diagrams

  Overview

Companies Metrics Content Purchase

Call Oveda Slade at 919-403-6583 to get your own copy of "Business Development: Accelerating the Deal" today.
 
Charts and Graphics
 

EXECUTIVE SUMMARY
Figure E.1:Deal-Making Challenges..............11
Figure E.2: Business Development Annual Budgets: Companies With Budgets Greater Than $1 Million..............18
Figure E.3: Company G: Identification for Therapeutic Areas Covered by General Business Development..............21
Figure E.4: Company O: Decision-Making Process..............22

 

BUSINESS DEVELOPMENT BUDGETS, STRUCTURE AND STRATEGY
Figure 1.1: Centralization of Business Development Functions..............26
Figure 1.2: Business Development Annual Budgets: Companies with Budgets Less Than $1 Million..............27

Business Development Budgets
Figure 1.3: Business Development Annual Budgets: Companies with Budgets Greater Than $1 Million..............28
 

Business Development and Licensing Structure
Figure 1.4: Business Development Staffing: Companies With 10 or More FTEs..............33
Figure 1.5: Business Development Staffing: Companies With Fewer Than 10 FTEs..............34
Figure 1.6: Company L’s Business Development Structure..............35
Figure 1.7: Company M’s Split System..............37
Figure 1.8: Company L’s Small BU Business Development Reporting Relationships..............41
Figure 1.9: Company O’s BD&L Structure..............46
Figure 1.10: Company Q’s Structure..............48
Figure 1.11: Company L’s Primary Care BD&L Function..............49
Figure 1.12: Company L’s BD&L Finance Team..............50
Figure 1.13: Reasons for Pursuing New Deals..............55

Business Development Strategy
Figure 1.14: Licensing Enters the Pipeline..............56
Figure 1.15: Phases in Which Companies Focus for In-Licensing Deals..............57
Figure 1.16: Phases in Which Companies Focus for Out-Licensing Deals..............58
Figure 1.17: Phases in Which Companies Focus for Inbound, Co-Development Deals..............58
Figure 1.18: Phases in Which Companies Focus for Outbound, Co-Development Deals..............59
Figure 1.19: Phases in Which Companies Focus for Inbound, Co-Promotion Deals..............60
Figure 1.20: Phases in Which Companies Focus for Outbound, Co-Promotion Deals..............60
Figure 1.21: Company T’s Licensing Strategy Structure..............65

 

OPPORTUNITY IDENTIFICATION AND EVALUATION
Figure 2.1: Structure of Deal Identification Process..............74
Figure 2.2: Deal Challenges: Deal Identification and Evaluation..............75
Figure 2.3: Deal Challenges: Identifying Deal Opportunities (by Company)..............75
Figure 2.4: Deal Challenges: Establishing Partner Relationships (by Company)..............76
Figure 2.5: Company M’s Basic Market Assessment..............78
Figure 2.6: Company O’s Identification Process..............79
Figure 2.7: Company G: Identification Structure for Therapeutic Areas Covered by General Business Development..............80
Figure 2.8: Company G: Identification Structure for Therapeutic Areas Covered by Therapeutically Aligned BD..............81

Best Practices
Figure 2.9: Company P’s Alliance Review Process..............88

The Deal Identification and Evaluation Process
Figure 2.10: Company O’s Decision-Making Process..............93

 

DUE DILIGENCE
Figure 3.1: Deal Challenges: Due Diligence..............100
Figure 3.2: Master Due Diligence Model..............101
Figure 3.3: Warning Signs..............102

Goals and Investments
Figure 3.4: Duration of Due Diligence..............103
Figure 3.5: Due Diligence Investment..............103
Figure 3.6: Company G’s Due Diligence Considerations..............107

Cooperation in Due Diligence
Figure 3.7: Business Development Staffing By Deal Stage: Companies With Up to 10 Cumulative FTEs..............112

Cross-Functional Involvement
Figure 3.8: Business Development Staffing By Deal Stage: Companies With More Than 10 Cumulative FTEs..............113
Figure 3.9: Inbound Deals: Functions Involved in Due Diligence..............114
Figure 3.10: Outbound Deals: Functions Involved in Due Diligence..............114
Figure 3.11: Prevalence of Tools Used to Estimate Potential ROI..............121

Deal Negotiation and Finalization
Figure 4.1: Deal Challenges..............128
Figure 4.2: Business Development Staffing By Deal Stage: Companies With Up to 10 Cumulative FTEs..............136
Figure 4.3: Business Development Staffing By Deal Stage: Companies With More Than 10 Cumulative FTEs..............137
Figure 4.4: Inbound Deals: Functions Involved in Deal Negotiation/Finalization..............139
Figure 4.5: Outbound Deals: Functions Involved in Deal Negotiation/Finalization..............139

 

BUSINESS DEVELOPMENT DEAL PROFILES
9 Deal Profiles that Contain the Following Data Points:

Deal Background

  • Type of Deal
  • Number of Bids Solicited
  • Anticipated Peak Annual Sales
  • Groups Involved in Steps of Deal-Making Process

Timing and Decision-Making

  • Investment in Deal-Making Process
  • Time to Complete Due Diligence
  • Average Cost of Due Diligence
  • Division of Control for Clinical Development and Marketing Decisions

Finances and Key Challenge

  • Royalty Percentage
  • Milestone Payment Triggers
  • Key Challenge to Deal Success

 

 

 


CORPORATE INFO RESEARCH REPORTS CONSULTING NEWS CONTACT US HOME
Copyright (c) Cutting Edge Information  p:919-403-6583  Please read our Copyright Policy